2,664
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes

, , , , , , , , , , , , , & ORCID Icon show all
Pages 3434-3454 | Received 12 Apr 2021, Accepted 16 Jun 2021, Published online: 12 Jul 2021

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. Epub 2018/ 09/13 PubMed PMID: 30207593.
  • Arnold M, Laversanne M, Brown LM, et al. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: international Trends in Incidence up to 2030. Am J Gastroenterol. 2017;112(8):1247–1255. Epub 2017/ 06/07 PubMed PMID: 28585555.
  • Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. Epub 2017/ 07/28 PubMed PMID: 28748917; PubMed Central PMCID: PMCPMC6168059.
  • Coleman HG, Xie S-H, Lagergren J. The Epidemiology of Esophageal Adenocarcinoma. Gastroenterology. 2018;154(2):390–405. Epub 2017/ 08/07. PubMed PMID: 28780073.
  • Lyamzaev KG, Tokarchuk AV, Panteleeva AA, et al. Induction of autophagy by depolarization of mitochondria. Autophagy. 2018;14(5):921–924. Epub 2018/ 02/21. PubMed PMID: 29458285; PubMed Central PMCID: PMCPMC6070013.
  • Hernández-Tiedra S, Fabriàs G, Dávila D, et al. Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization. Autophagy. 2016;12(11):2213–2229. Epub 2016/ 11/02. PubMed PMID: 27635674; PubMed Central PMCID: PMCPMC5103338.
  • Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542. Epub 2017/ 07/29. PubMed PMID: 28751651; PubMed Central PMCID: PMCPMC5975367.
  • Saxena S, Klochkova K, Murray MG, et al. Roles for Autophagy in Esophageal Carcinogenesis: implications for Improving Patient Outcomes. Cancers (Basel). 2019;11(11):1697. Epub 2019/ 11/07. PubMed PMID: 31683722; PubMed Central PMCID: PMCPMC6895837.
  • Kong J, Whelan KA, Laczkó D, et al. Autophagy levels are elevated in barrett’s esophagus and promote cell survival from acid and oxidative stress. Mol Carcinog. 2016;55(11):1526–1541. Epub 2015/ 09/17. PubMed PMID: 26373456; PubMed Central PMCID: PMCPMC4794420.
  • Roesly HB, Khan MR, Chen HDR, et al. The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. Am J Physiol Gastrointest Liver Physiol. 2012; 302(8):G864–72. Epub 2012/ 02/04. PubMed PMID: 22301112; PubMed Central PMCID: PMCPMC3355563.
  • Adams O, Janser FA, Dislich B, et al. A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PLoS One. 2018;13(6):e0197610. Epub 2018/ 06/14. PubMed PMID: 29897944; PubMed Central PMCID: PMCPMC5999293.
  • Adams O, Dislich B, Berezowska S, et al. Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas. Oncotarget. 2016;7(26):39241–39255. Epub 2016/ 10/27. PubMed PMID: 27250034; PubMed Central PMCID: PMCPMC5129929.
  • Chen C, Chen S, Cao H, et al. Prognostic significance of autophagy-related genes within esophageal carcinoma. BMC Cancer. 2020;20(1):797. Epub 2020/ 08/25. PubMed PMID: 32831056; PubMed Central PMCID: PMCPMC7446118.
  • Du H, Xie S, Guo W, et al. Development and validation of an autophagy-related prognostic signature in esophageal cancer. Ann Transl Med. 2021;9(4):317. Epub 2021/ 03/13. PubMed PMID: 33708944; PubMed Central PMCID: PMCPMC7944288.
  • Zhu L, Dong L, Feng M, et al. Profiles of autophagy-related genes in esophageal adenocarcinoma. BMC Cancer. 2020;20(1):943. Epub 2020/ 10/02. PubMed PMID: 32998713; PubMed Central PMCID: PMCPMC7528598.
  • Xu T, Yuan Y, He C, et al. Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma. Med Sci Monit Epub 2021/ 01/30. PubMed PMID: 33510126; PubMed Central PMCID: PMCPMC7852040. 2021;27:e927850
  • Huang Y, Liu Z, He L, et al. Radiomics Signature: a Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer. Radiology. 2016;281(3):947–957. Epub 2016/ 06/28. PubMed PMID: 27347764.
  • Valentini V, van Stiphout RG, Lammering G, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29(23):3163–3172. Epub 2011/ 07/13. PubMed PMID: 21747092.
  • Kavanagh ME, Conroy MJ, Clarke NE, et al. Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma. Cancer Lett. 2016;370(1):117–124. Epub 2015/ 11/01. PubMed PMID: 26519754.
  • Yang W, Han Y, Zhao X, et al. Advances in prognostic biomarkers for esophageal cancer. Expert Rev Mol Diagn. 2019;19(2):109–119. Epub 2018/ 12/26. PubMed PMID: 30582379.
  • Mo R, Chen C, Pan L, et al. Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8(th) edition of the TNM staging system for esophageal cancer? J Thorac Dis. 2018;10(9):5192–5198. Epub 2018/ 11/13. PubMed PMID: 30416766; PubMed Central PMCID: PMCPMC6196162.
  • Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14(2):207–215. Epub 2017/ 09/22. PubMed PMID: 28933638; PubMed Central PMCID: PMCPMC5902171.
  • Weh KM, Howell AB, Kresty LA. Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma. Mol Carcinog. 2016;55(11):1876–1885. Epub 2016/ 10/04. PubMed PMID: 27696537; PubMed Central PMCID: PMCPMC5987534.
  • O’Donovan TR, O’Sullivan GC, McKenna SL. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy. 2011;7(5):509–524. Epub 2011/ 02/18. PubMed PMID: 21325880; PubMed Central PMCID: PMCPMC3127212.
  • El-Mashed S, O’Donovan TR, Kay EW, et al. LC3B globular structures correlate with survival in esophageal adenocarcinoma. BMC Cancer. 2015;15:582. Epub 2015/ 08/13PubMed PMID: 26265176; PubMed Central PMCID: PMCPMC4533787.
  • Karamichalis R, Kari L, Konstantinidis S, et al. Additive methods for genomic signatures. BMC Bioinformatics. 2016;17(1):313. Epub 2016/ 08/24. PubMed PMID: 27549194; PubMed Central PMCID: PMCPMC4994249.
  • Chlis N-K, Bei ES, Zervakis M. Introducing a Stable Bootstrap Validation Framework for Reliable Genomic Signature Extraction. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 2018;15(1):181–190. Epub 2016/ 12/04. PubMed PMID: 27913357.
  • Gu Y, Li P, Peng F, et al. Autophagy-related prognostic signature for breast cancer. Mol Carcinog. 2016;55(3):292–299. Epub 2015/ 01/27. PubMed PMID: 25620657.
  • An Y, Bi F, You Y, et al. Development of a Novel Autophagy-related Prognostic Signature for Serous Ovarian Cancer. J Cancer. 2018;9(21):4058–4071. Epub 2018/ 11/10. PubMed PMID: 30410611; PubMed Central PMCID: PMCPMC6218776.
  • Zhou Z, Mo S, Dai W, et al. Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer. Front Oncol. 2019;9:878. Epub 2019/ 09/26PubMed PMID: 31552190; PubMed Central PMCID: PMCPMC6746211.
  • Lin P, He R-Q, Dang Y-W, et al. An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients. Oncotarget. 2018;9(25):17368–17395. Epub 2018/ 05/01. PubMed PMID: 29707114; PubMed Central PMCID: PMCPMC5915122.
  • Wang X, Yao S, Xiao Z, et al. Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes. J Transl Med. 2020;18(1):149. Epub 2020/ 04/03. PubMed PMID: 32238163; PubMed Central PMCID: PMCPMC7115085.
  • Huang F, Wang B-R, Wang Y-G. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma. World J Gastroenterol. 2018;24(41):4643–4651. Epub 2018/ 11/13. PubMed PMID: 30416312; PubMed Central PMCID: PMCPMC6224467.
  • Zheng K, He Z, Kitazato K, et al. Selective Autophagy Regulates Cell Cycle in Cancer Therapy. Theranostics. 2019;9(1):104–125. Epub 2019/ 01/22. PubMed PMID: 30662557; PubMed Central PMCID: PMCPMC6332805.
  • Richardson TE, Tang K, Vasudevaraja V, et al. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors. J Neuropathol Exp Neurol. 2019;78(12):1089–1099. Epub 2019/ 10/19. PubMed PMID: 31626289.
  • Matboli M, Shafei AE, Ali MA, et al. Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 axis expression in malignant pleural mesothelioma. J Cell Biochem. 2019;120(3):3203–3211. Epub 2018/ 10/27. PubMed PMID: 30362153.
  • Slattery ML, John EM, Stern MC, et al. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat. 2013;140(3):587–601. Epub 2013/ 08/06. PubMed PMID: 23912956; PubMed Central PMCID: PMCPMC3860319.
  • Antonia RJ, Castillo J, Herring LE, et al. TBK1 Limits mTORC1 by Promoting Phosphorylation of Raptor Ser877. Sci Rep. 2019;9(1):13470. Epub 2019/ 09/19. PubMed PMID: 31530866; PubMed Central PMCID: PMCPMC6748941.
  • Durand JK, Zhang Q, Baldwin AS. Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer. Cells. 2018;7(9):139. Epub 2018/ 09/19. PubMed PMID: 30223576; PubMed Central PMCID: PMCPMC6162516.
  • Sarraf SA, Sideris DP, Giagtzoglou N, et al. PINK1/Parkin Influences Cell Cycle by Sequestering TBK1 at Damaged Mitochondria, Inhibiting Mitosis. Cell Rep. 2019;29(1):225–35.e5. Epub 2019/ 10/03. PubMed PMID: 31577952; PubMed Central PMCID: PMCPMC6880866.
  • Xiao Y, Zou Q, Xie X, et al. The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. J Exp Med. 2017;214(5):1493–1507. Epub 2017/ 03/31. PubMed PMID: 28356390; PubMed Central PMCID: PMCPMC5413337.
  • Ma M-C, Chiu T-J, Lu H-I, et al. SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma. J Cardiothorac Surg. 2018;13(1):25. Epub 2018/ 04/11. PubMed PMID: 29636061; PubMed Central PMCID: PMCPMC5894223.
  • Qin T, Liu W, Huo J, et al. SIRT1 expression regulates the transformation of resistant esophageal cancer cells via the epithelial-mesenchymal transition. Biomed Pharmacother. 2018;10:5192–5198. Epub 2018/ 04/16PubMed PMID: 29656187.
  • Yamashita K, Miyata H, Makino T, et al. High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2018;10(9):5192–5198. Epub 2017/ 10/13. PubMed PMID: 29022200.
  • Noble F, Mellows T, McCormick Matthews LH, et al. Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma. Cancer Immunol Immunother. 2016;65(6):651–662. Epub 2016/ 03/30. PubMed PMID: 27020682; PubMed Central PMCID: PMCPMC4880639.
  • Janser FA, Adams O, Bütler V, et al. Her2-Targeted Therapy Induces Autophagy in Esophageal Adenocarcinoma Cells. Int J Mol Sci. 2018;19(10):3069. Epub 2018/ 10/10. PubMed PMID: 30297650; PubMed Central PMCID: PMCPMC6213363.
  • Lozy F, Cai-McRae X, Teplova I, et al. ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss. Autophagy. 2014;10(4):662–676. Epub 2014/ 02/05. PubMed PMID: 24492513; PubMed Central PMCID: PMCPMC4091153.
  • De Silva N, Schulz L, Paterson A, et al. Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma. Br J Cancer. 2015;113(9):1305–1312. Epub 2015/ 10/21. PubMed PMID: 26484410; PubMed Central PMCID: PMCPMC4815800.
  • Zhao D, Klempner SJ, Chao J. Progress and challenges in HER2-positive gastroesophageal adenocarcinoma. J Hematol Oncol. 2019;12(1):50. Epub 2019/ 05/19. PubMed PMID: 31101074; PubMed Central PMCID: PMCPMC6525398.